Akero Therapeutics CDO Sells Shares Worth Over $230,000

InvestingSep 18 21:22 ET

H.C. Wainwright Maintains Akero Therapeutics(AKRO.US) With Buy Rating, Maintains Target Price $50

Moomoo NewsSep 16 11:31 ET · Ratings

Oxford Industries Reports Weak Results, Joins Viper Energy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

BenzingaSep 12 08:02 ET

Wellington Management Group LLP's Strategic Acquisition in Akero Therapeutics Inc

Yahoo FinanceSep 12 01:12 ET

Akero Therapeutics' Promising Phase 3 Programs Bolster Buy Rating

TipRanksSep 10 05:56 ET · Ratings

Express News | Akero Therapeutics Inc - Phase 2B Symmetry Study Results Expected in Q1 2025

ReutersSep 9 07:00 ET